One of our ELPCSG members (and ex-committee member) Rob Lester has been in correspondence with his MSP about access to new cancer drugs, and his personal experience of Abiraterone (Zytiga). Rob has very kindly agreed to share this correspondence with ELPCSG members, and we anticipate that this will be of great interest. It is encouraging that the manufacturer of Abiraterone (Zytiga), Janssen-Cilag Ltd., is considering an application regarding Abiraterone (Zytiga) to the Scottish Medicines Council for its use within NHS Scotland. Rob’s initial e-mail is here and the reply letter from Jeane Freeman, Cabinet Secretary for Health and Sport to Rob’s MSP, here.